Sweet Earth Holdings Corp. ( CSE: SE ) ( FSE: 1KZ1 ) ( OTCQB: SEHCF ) (" Sweet Earth " the " Company ") is pleased to announce results from its In Vitro Release Testing (" IVRT ") Product Research Program (the " R&D Program ") that is being conducted with NAVCO Pharmaceuticals Limited (" Navco "), an accredited laboratory located in Burlington, Ontario. The purpose of the Company's R&D Program is to maximize efficacy of its... Read More